JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
2,188,301
2,161,761
1,890,922
1,618,693
1,487,973
Cost of revenue
123,081
127,930
121,544
110,188
105,386
Gross profit
2,065,220
2,033,831
1,769,378
1,508,505
1,382,587
Operating expenses
Research development
325,728
299,726
226,616
198,442
162,297
Selling general and administrative
777,395
736,942
683,530
544,156
502,892
Total operating expenses
1,463,899
1,391,482
1,111,644
894,663
767,183
Operating income or loss
601,321
642,349
657,734
613,842
615,404
Total other income/expenses net
-398,696
-115,786
-51,196
-94,969
-21,016
Income before tax
129,790
454,302
529,463
441,117
532,446
Income tax expense
-153,557
-73,154
80,162
-47,740
135,236
Income from continuing operations
280,333
523,367
447,098
487,848
396,831
Net income
280,333
523,367
447,098
487,848
396,831
Net income available to common shareholders
280,333
523,367
447,098
487,848
396,831
Basic EPS
-
9.22
7.45
8.13
6.56
Diluted EPS
-
9.09
7.30
7.96
6.41
Basic average shares
-
56,749
59,976
60,018
60,500
Diluted average shares
-
57,550
61,221
61,317
61,870
EBITDA
-
1,012,505
874,465
778,996
729,184